Literature DB >> 26508204

Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.

Masaharu Akiyama1,2, Masayoshi Yamaoka3, Yoko Mikami-Terao3, Wataru Ohyama3, Kentaro Yokoi3, Yasuhiro Arakawa4, Junko Takita5, Hideaki Suzuki6, Hisashi Yamada7.   

Abstract

Maffucci syndrome is a nonhereditary congenital disorder characterized by multiple enchondromas and with soft-tissue hemangiomas. Somatic mutations of the isocitrate dehydrogenase (IDH) gene have been detected in enchondroma and hemangioma tissue from patients with Maffucci syndrome. The rate of malignant transformation in Maffucci syndrome is high, with enchondromas transforming into chondrosarcomas and the development of secondary neoplasms, including pancreatic and hepatic adenocarcinoma, mesenchymal ovarian tumors, and brain tumors such as glioma. However, hematopoietic malignancies arising in Maffucci syndrome are rare. We report a 7-year-old girl with Maffucci syndrome in whom acute myeloid leukemia (AML) with cup-like nuclear invagination developed. Both leukemic cells and hemangioma had the same gene mutations: an insertion frameshift c.863_864insTCTG (p.W288 fs) in the nucleophosmin (NPM1) gene and a missense mutation c.392_395GTCG > CTCT (p.G131_R132 > AL) in the IDH1 gene. However, buccal mucosa cells and peripheral blood mononuclear cells harvested after two cycles of chemotherapy showed wild-type genotypes. These results suggest that the multiple somatic mutations of the IDH1 and NPM1 genes in hemangioblasts are related to the development of cup-like AML associated with Maffucci syndrome. However, further studies are needed to identify additional molecular events in AML but not in hemangioma.

Entities:  

Keywords:  Acute myeloid leukemia; Hemangioma; Isocitrate dehydrogenase; Maffucci syndrome; Nucleophosmin

Mesh:

Substances:

Year:  2015        PMID: 26508204     DOI: 10.1007/s12185-015-1892-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  Acute myelogenous leukemia associated with Ollier disease.

Authors:  Matthew S White; Paul L Martin; Thomas W McLean
Journal:  Pediatr Blood Cancer       Date:  2008-03       Impact factor: 3.167

2.  Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.

Authors:  Borae G Park; Hyun-Sook Chi; Seongsoo Jang; Chan-Jeoung Park; Dae-Young Kim; Jung-Hee Lee; Je-Hwan Lee; Kyoo-Hyung Lee
Journal:  Ann Hematol       Date:  2012-12-13       Impact factor: 3.673

3.  Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Authors:  Konstanze Döhner; Richard F Schlenk; Marianne Habdank; Claudia Scholl; Frank G Rücker; Andrea Corbacioglu; Lars Bullinger; Stefan Fröhling; Hartmut Döhner
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

4.  Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Authors:  Christian Thiede; Sina Koch; Eva Creutzig; Christine Steudel; Thomas Illmer; Markus Schaich; Gerhard Ehninger
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

5.  IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies.

Authors:  K Oki; J Takita; M Hiwatari; R Nishimura; M Sanada; J Okubo; M Adachi; M Sotomatsu; A Kikuchi; T Igarashi; Y Hayashi; S Ogawa
Journal:  Leukemia       Date:  2011-01-14       Impact factor: 12.883

6.  Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation.

Authors:  Weina Chen; Sergej Konoplev; L Jeffrey Medeiros; Hartmut Koeppen; Vasiliki Leventaki; Saroj Vadhan-Raj; Dan Jones; Hagop M Kantarjian; Brunangelo Falini; Carlos E Bueso-Ramos
Journal:  Cancer       Date:  2009-12-01       Impact factor: 6.860

7.  Chronic myeloid leukemia in an adolescent with Ollier's disease after intensive X-ray exposure.

Authors:  W Y Au; G C Ooi; S K Ma; T S K Wan; Y L Kwong
Journal:  Leuk Lymphoma       Date:  2004-03

8.  Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.

Authors:  Twinkal C Pansuriya; Ronald van Eijk; Pio d'Adamo; Maayke A J H van Ruler; Marieke L Kuijjer; Jan Oosting; Anne-Marie Cleton-Jansen; Jolieke G van Oosterwijk; Sofie L J Verbeke; Daniëlle Meijer; Tom van Wezel; Karolin H Nord; Luca Sangiorgi; Berkin Toker; Bernadette Liegl-Atzwanger; Mikel San-Julian; Raf Sciot; Nisha Limaye; Lars-Gunnar Kindblom; Soeren Daugaard; Catherine Godfraind; Laurence M Boon; Miikka Vikkula; Kyle C Kurek; Karoly Szuhai; Pim J French; Judith V M G Bovée
Journal:  Nat Genet       Date:  2011-11-06       Impact factor: 41.307

9.  IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.

Authors:  Peter Paschka; Richard F Schlenk; Verena I Gaidzik; Marianne Habdank; Jan Krönke; Lars Bullinger; Daniela Späth; Sabine Kayser; Manuela Zucknick; Katharina Götze; Heinz-A Horst; Ulrich Germing; Hartmut Döhner; Konstanze Döhner
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 50.717

10.  IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome.

Authors:  Kunihiko Moriya; Mika K Kaneko; Xing Liu; Masami Hosaka; Fumiyoshi Fujishima; Jun Sakuma; Satoshi Ogasawara; Mika Watanabe; Yoji Sasahara; Shigeo Kure; Yukinari Kato
Journal:  Cancer Sci       Date:  2014-03       Impact factor: 6.518

View more
  1 in total

Review 1.  Germline Predisposition to Hematolymphoid Neoplasia.

Authors:  Olga K Weinberg; Frank Kuo; Katherine R Calvo
Journal:  Am J Clin Pathol       Date:  2019-08-01       Impact factor: 2.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.